Open AccessRibociclib Plus Fulvestrant for HR+, HER2- Advanced Breast Cancer
Author(s) -
Francisco J. Esteva
Publication year - 2018
Publication title -
oncology times
Language(s) - Danish
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000550763.80370.87
Subject(s) - fulvestrant , palbociclib , medicine , oncology , cancer , adjuvant , breast cancer , metastatic breast cancer , gynecology , tamoxifen